Responsibilities

• Lead the development and evolution of patient commercial strategy to maximize growth across CIDP and MMN.
• Identify and unlock growth levers across awareness, consideration, therapy initiation, persistence, and lifecycle management.
• Strengthen competitive positioning and reinforce differentiated value within the treatment paradigm.
• Drive omnichannel optimization using rigorous performance analytics and agile measurement.
• Expand addressable market through targeted patient segment strategies and ecosystem partnerships.
• Partner closely with HCP, Market Access, Medical, Patient Support Services and Patient Advocacy to remove friction points across the patient journey.
• Co-Lead proactive competitive response planning and scenario modeling.
• Define clear roles, positioning, and treatment sequencing for Vyvgart and Empa across CIDP and MMN.
• Develop a franchise-level value narrative that clarifies differentiation while reinforcing complementary strengths.
• Prevent internal cannibalization through disciplined segmentation and treatment pathway strategy.

Requirements

• 12-15+ years of biopharma commercial experience.
• Demonstrated success driving performance of an in-market brand.
• Launch experience required.
• Experience managing multi-asset or multi-indication portfolios strongly preferred.
• MBA or advanced degree preferred.

Preferred

• Deep patient marketing expertise in specialty or rare disease markets preferred.

Benefits

• This job is eligible to participate in our short-term and long-term incentive programs, subject to the terms and conditions of those plans and applicable policies.
• It also includes a comprehensive benefits package, including but not limited to retirement savings plans, health benefits and other benefits subject to the terms of the applicable plans and program guidelines.